Overview


Whole blood is the whole blood that flows through our bodies. The process of phlebotomy and hemapheresis, which uses differential centrifugation to extract blood components, such as platelets or plasma, red blood cells, white blood cells, and red blood cells, allows them to be taken from blood. These blood components are removed from whole blood in hospitals laboratories and blood centers and given to patients who have various diseases via transfusion. The whole blood is sometimes collected and then separated into major components for transfusion. Nowadays, the automated collection is becoming more popular. Only the necessary blood components are collected. Patients receiving transfusions typically do not require all the elements. One pint (or one unit) of whole blood is processed by spinning into a red blood cell, which provides oxygen to anemic patients; platelets for bleeding patients; and plasma, which is transfused in patients whose blood isn't clotting. The whole blood is composed of platelets and plasma, red cells, and granulocytes. However, blood components are leukocytes reduced RBC, packed cells, frozen plasma, and platelet concentrate. The market for blood preparations can be classified according to their antithrombotic and anticoagulant classifications. The global blood preparation market has grown due to the increasing demand for blood transfusions in hospitals and emergency departments. This market has grown due to the rising incidence of blood disorders like thrombocytosis as well as the need for blood during surgery and accidents. Market growth is being supported by the growing demand for blood preparation, high-quality blood during surgical procedures, and an increase in blood disorders that compensate for severe blood loss. Market growth is also expected to be driven by rising blood disorders prevalence and increasing emergency surgeries in hospitals. The accurate diagnosis of hemorrhagic disorders has been made easier by advanced blood testing technologies. Other factors include the growing demand for blood, and its component due to increased target diseases, accidents, and surgeries. This will drive the blood preparation market over the forecast period. Global blood preparation market growth is expected to be fueled by rising emergency cases and increased demand for blood transfusion. Blood transfusion can lead to the transmission of the viral hemorrhagic virus, HIV, and Hepatitis A. This is the biggest limiting factor affecting the growth and development of the global blood preparation industry. High-speed technology for separating blood components quickly without losing their activity offers a huge opportunity for the overall market to grow.
FutureWise Market Research has instantiated a report that provides an intricate analysis of Blood Preparation Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.
According to the research study conducted by FutureWise research analysts, the Blood Preparation Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

• GlaxoSmithKline Plc
• Baxter Healthcare Corp
• Pfizer Inc
• Bristol-Myers Squibb Company
• Sanofi Aventis
• AstraZeneca Plc
• Celgene Corporation
• Leo Pharma A/S
• Portola Pharmaceuticals Inc
• Shandong East Chemical Industry Co.
(Note: The list of the major players will be updated with the latest market scenario and trends)

By Product Type
• Whole Blood
o RBC
o Plasma
o Platelets
• Blood Components
o Whole Blood Components
o Packed Red Cells
o Leukocyte Reduced Red Blood Cells
o Frozen Plasma
o Platelet Concentrate
o Cryoprecipitate
• Blood Derivatives
By Application
• Thrombocytosis
• Pulmonary Embolism
• Renal Impairment
• Angina Blood Vessel Complications
• Others
By End User
• Hospitals
• Clinics
• Diagnostic Centers
• Research labs
• Blood Banks
• Pharmaceuticals
• Others
By Region
North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

• Growth prospects
• SWOT analysis
• Key trends
• Key data-points affecting market growth

• To provide with an exhaustive analysis on the Blood Preparation Market By Product Type, By Application, By End User and By Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

• We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
• The customization Mobility Care offered are free of charge with purchase of any license of the report
• You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Blood Preparation Market Variables, Trends
    • Scope
        1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances
  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Blood Preparation Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Blood Preparation Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Blood Preparation Market, By Product Type Historical Analysis and Forecast 2022-2028 (USD Million)
    •   1. Whole Blood
         1.1. RBC
         1.2. Plasma
         1.3. Platelets
        2. Blood Components
         2.1. Whole Blood Components
         2.2. Packed Red Cells
         2.3. Leukocyte Reduced Red Blood Cells
         2.4. Frozen Plasma
         2.5. Platelet Concentrate
         2.6. Cryoprecipitate
        3. Blood Derivatives
  • 8.   Blood Preparation Market, By Application Historical Analysis and Forecast 2022-2028 (USD Million)
    •   1. Thrombocytosis
        2. Pulmonary Embolism
        3. Renal Impairment
        4. Angina Blood Vessel Complications
        5. Others
  • 9.   Blood Preparation Market, By End User Historical Analysis and Forecast 2022-2028 (USD Million)
    •   1. Hospitals
        2. Clinics
        3. Diagnostic Centers
        4. Research labs
        5. Blood Banks
        6. Pharmaceuticals
        7. Others
  • 10.   North America Blood Preparation Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
           2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2022-2028
  • 11.   Latin America Blood Preparation Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2022-2028
  • 12.   Europe Blood Preparation Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         2.1. Germany
          2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2022-2028
  • 13.   Asia Pacific Blood Preparation Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028
  • 14.   Middle East and Africa Market Analysis 2016-2020 and Forecast 2022-2028 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2016-2020
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2022-2028
  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. GlaxoSmithKline Plc
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Baxter Healthcare Corp
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Pfizer Inc
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Bristol-Myers Squib
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Sanofi Aventis
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. AstraZeneca Plc
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Celgene Corporation
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Leo Pharma A/S
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Portola Pharmaceuticals Inc
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Shandong East Chemical Industry Co.
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients